On Tuesday, Pliant Therapeutics Inc (PLRX) stock saw a decline, ending the day at $10.55 which represents a decrease of $-0.66 or -5.89% from the prior close of $11.21. The stock opened at $11.15 and ...

Tim Walz versus J.D. Vance was the anti-Trump debate. There were no references to the animal kingdom in this ...

"We are pleased to welcome Chris as we enter the next phase of our growth," said Alignable CEO & Co-Founder Eric Groves. "His expertise in scaling companies and his strategic vision will be invaluable ...

Former Bristol Myers Squibb Global Medical Affairs Lead brings over 25 years of experience to Pliant SOUTH SAN FRANCISCO, ...

Broadcast intercom systems play a crucial role in coordinating complex productions and ensuring clear communication ... Read ...

Pliant Therapeutics, Inc. (Nasdaq: PLRX), today announced that on September 30, 2024 it granted stock options to purchase an ...

We look forward to presenting our latest intercom solutions at NAB NY 2024,” said Gary Rosen, Vice President of Global Sales ...

Performance is not exciting but when faced with a long traffic from Noida to Delhi, that's not one of your concerns. In plan ...

As a closer look at Trump’s rhetoric shows, it’s clear that he feels threatened by Zelensky, whom he has called "the greatest ...

Oppenheimer analyst Jeff Jones maintained a Buy rating on Pharming Group (PHAR – Research Report) today and set a price target of $31.00.

A NATIONWIDE bamboo planting activity and a municipal ordinance institutionalizing the implementation of the pliant tree for ...

During the build-up to the 44th Sadc Summit, police swooped on 78 Citizens Coalition for Change members gathered at the ...